Malignant Hyperthermia and Ryanodine Receptor Type 1 Gene (RyR1) Mutation in a Family in Singapore.
- Author:
Daphne Wy LI
1
;
Poh San LAI
;
Delice W LEE
;
Rita Yy YONG
;
Tat Leang LEE
Author Information
- Publication Type:Journal Article
- From:Annals of the Academy of Medicine, Singapore 2017;46(12):455-460
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTIONSporadic clinical episodes of malignant hyperthermia (MH) that develop during general anaesthesia (GA) have been reported in Singapore. However, there is no published local report of a confirmed case of MH susceptibility (MHS) by skeletal muscle contracture tests and/or molecular tests.
MATERIALS AND METHODSWe report 2 patients from an extended family who developed signs of clinical MH while under GA. The MH episodes were successfully treated with intravenous dantrolene sodium. Sequence analysis of the entirecoding gene was carried out in an index patient.
RESULTSThe index patient was found to carry a c.7373G>A (p.Arg2458His) mutation in exon 46. This particular mutation satisfies the criteria for a MHS causative mutation. Hence, the index patient was considered to be MHS and did not need to undergo further muscle contracture testing. The same mutation was also found in 3 other members of his extended family.
CONCLUSIONThis is the first report of a Singaporean family with at least 4 members carrying a MH-causative mutation ingene. This report serves to highlight the existence of the putative gene for MH in Singapore, and the need for clinical vigilance during anaesthesia involving the use of triggering agents.